National Summary Report
Latest data from June 17, 2022
The Health Resources and Services Administration uses the information collected to: help track health center capacity and the impact of COVID-19 on health center operations, patients, and staff; and better understand training and technical assistance, funding, and other health center resource needs.
Health Center COVID-19 Survey Tool Questions
Health Center COVID-19 Survey Tool User Guide
View Health Center Survey Data for COVID-19
Number of Look-Alike respondents = 55 (52% of all Look-Alike Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 6,863 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 49.78% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 825 |
| Racial and/or Ethnic Minority Patients | 45.95% |
Patients Tested by Race and Ethnicity
| Race/Ethnicity | Patients Tested by race and ethnicity, Virus Detection (PCR, antigen)2 | Patients Tested Positive by race and ethnicity, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 45.62% | 50.18% |
| White, Hispanic/Latino Patients | 18.72% | 17.21% |
| Black/African American, Non-Hispanic/Latino Patients | 10.86% | 11.88% |
| Black/African American, Hispanic/Latino Patients | 1.52% | 1.58% |
| Asian Patients3 | 2.68% | 3.76% |
| American Indian/Alaska Native Patients3 | 0.77% | 1.70% |
| Native Hawaiian/Other Pacific Islander Patients3 | 1.06% | 1.09% |
| Patients with More Than One Race3 | 3.16% | 1.70% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 6.45% | 3.76% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.59% | 2.06% |
| Unreported/Refused to Report Race and Ethnicity | 6.56% | 5.09% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 997 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 56.18% |
| COVID-19 Immunization Series Completed | 563 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 62.76% |
| COVID-19 Immunization Series Additional | 1,606 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 70.12% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 42.33% | 35.52% | 27.09% |
| White, Hispanic/Latino Patients | 17.05% | 17.58% | 11.02% |
| Black/African American, Non-Hispanic/Latino Patients | 20.66% | 25.40% | 16.31% |
| Black/African American, Hispanic/Latino Patients | 3.81% | 2.31% | 1.12% |
| Asian Patients3 | 3.71% | 5.15% | 9.22% |
| American Indian/Alaska Native Patients3 | 0.20% | 0.53% | 13.14% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.60% | 0.36% | 0.75% |
| Patients with More Than One Race3 | 2.71% | 2.49% | 2.80% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 5.52% | 6.04% | 9.22% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.90% | 1.42% | 3.74% |
| Unreported/Refused to Report Race and Ethnicity | 2.51% | 3.20% | 5.60% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 32.73% |
| 1 to 24 Hours | 34.55% |
| More Than 24 Hours | 27.27% |
| N/A | 5.45% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 5.45% |
| Staffing to administer the vaccine | 14.55% |
| Vaccine confidence | 29.09% |
| Vaccine storage capacity | 5.45% |
| Vaccine supply | 1.82% |
| Other | 7.27% |
| None | 47.27% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 1.35% |
| Average Percent of Health Center Visits Conducted Virtually | 16.18% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 20.00% |
| Number of Mobile Van Sites | 14 |
| Number of Pop-up Clinics | 14 |
| Number of School-Based Vaccination Sites | 1 |
| Number of Family Vaccination Clinics | 8 |
Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Percent of Health Centers Providing Access to Monoclonal Antibody Therapy | 56.36% |
| Number of Doses of Monoclonal Antibodies Administered | 61 |
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 10.91% |
| Refer patients to another organization that provides monoclonal antibody therapies | 45.45% |
| None | 43.64% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 18.18% |
| Patient awareness/education | 10.91% |
| Staffing capacity | 14.55% |
| Therapy administration/onsite logistics | 21.82% |
| Other | 1.82% |
| None | 56.36% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Percent of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 56.36% |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 9,218 |
Test Kit Distribution Methods4
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 83.87% |
| Provided to General Public Who Came to the Health Center | 48.39% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 16.13% |
| Provided at Other Community Events | 25.81% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 6.45% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 16.13% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 9.68% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 6.45% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 3.23% |
| Other | 9.68% |
N95 Mask Distribution
| Metrics | Value |
|---|---|
| Percent of Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 30.91% |
| Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 13,547 |
N95 Mask Distribution Methods5
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 82.35% |
| Provided to General Public Who Came to the Health Center | 76.47% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 11.76% |
| Provided at Other Community Events | 41.18% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 0.00% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 23.53% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 23.53% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 17.65% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 0.00% |
| Other | 11.76% |
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Percent of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 0.58% |
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 | 29.63% |
Oral Antiviral Medication Distribution by Race and Ethnicity5
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 59.26% |
| White, Hispanic/Latino Patients | 3.70% |
| Black/African American, Non-Hispanic/Latino Patients | 3.70% |
| Black/African American, Hispanic/Latino Patients | 0.00% |
| Asian Patients3 | 7.41% |
| American Indian/Alaska Native Patients3 | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.00% |
| Patients with More Than One Race3 | 14.81% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 7.41% |
| Unreported/Refused to Report Race and Ethnicity | 3.70% |
Oral Antiviral Medication Distribution by Population Type
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 0.00% |
| Patients Experiencing Homelessness | 0.00% |
| Patients Who Are Residents of Public Housing | 0.00% |
| Patients with Limited English Proficiency | 3.70% |
| Children Under 18 Years of Age | 0.00% |
1 The reported number of patients tested does not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.
Date Last Reviewed: